TokenPost·
Stoke Therapeutics Expects Q3 2027 EMPEROR Readout and NDA Filing
About 110 of 162 enrolled patients had completed a week 28 visit. Stoke ended September with $358.8 million in cash and expects available funds, Biogen reimbursements and a potential milestone payment to support opera…